Amgen Inc (AMGN)
294.53
+4.63
(+1.60%)
USD |
NASDAQ |
Nov 22, 16:00
294.53
0.00 (0.00%)
Pre-Market: 20:00
Amgen Gross Profit Margin (Quarterly): 61.07% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 61.07% |
| June 30, 2024 | 61.42% |
| March 31, 2024 | 57.03% |
| December 31, 2023 | 62.03% |
| September 30, 2023 | 73.84% |
| June 30, 2023 | 74.05% |
| March 31, 2023 | 71.83% |
| December 31, 2022 | 74.46% |
| September 30, 2022 | 76.13% |
| June 30, 2022 | 77.10% |
| March 31, 2022 | 74.98% |
| December 31, 2021 | 74.91% |
| September 30, 2021 | 76.01% |
| June 30, 2021 | 74.92% |
| March 31, 2021 | 74.75% |
| December 31, 2020 | 75.93% |
| September 30, 2020 | 75.70% |
| June 30, 2020 | 76.02% |
| March 31, 2020 | 75.44% |
| December 31, 2019 | 79.78% |
| September 30, 2019 | 81.94% |
| June 30, 2019 | 82.76% |
| March 31, 2019 | 81.01% |
| December 31, 2018 | 82.41% |
| September 30, 2018 | 82.44% |
| Date | Value |
|---|---|
| June 30, 2018 | 83.10% |
| March 31, 2018 | 83.00% |
| December 31, 2017 | 81.75% |
| September 30, 2017 | 82.85% |
| June 30, 2017 | 82.38% |
| March 31, 2017 | 81.77% |
| December 31, 2016 | 82.11% |
| September 30, 2016 | 82.33% |
| June 30, 2016 | 81.54% |
| March 31, 2016 | 81.58% |
| December 31, 2015 | 80.65% |
| September 30, 2015 | 81.93% |
| June 30, 2015 | 79.72% |
| March 31, 2015 | 79.48% |
| December 31, 2014 | 77.81% |
| September 30, 2014 | 78.77% |
| June 30, 2014 | 79.13% |
| March 31, 2014 | 75.89% |
| December 31, 2013 | 79.47% |
| September 30, 2013 | 83.40% |
| June 30, 2013 | 83.22% |
| March 31, 2013 | 82.44% |
| December 31, 2012 | 79.14% |
| September 30, 2012 | 82.06% |
| June 30, 2012 | 83.20% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
57.03%
Minimum
Mar 2024
79.78%
Maximum
Dec 2019
72.37%
Average
74.91%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 69.01% |
| Eli Lilly and Co | 81.02% |
| Merck & Co Inc | 75.51% |
| Regeneron Pharmaceuticals Inc | 86.80% |
| Viking Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 65.35% |
| Return on Assets | 4.57% |
| Return on Invested Capital | 6.14% |
| Profit Margin (Quarterly) | 33.28% |
| Operating Margin (Quarterly) | 24.07% |
| Return on Net Operating Assets | 6.38% |